Sight Sciences officer proposes $224K share sale
Separately, the notice lists 55,087,990 shares outstanding and a July 2, 2026 sale of 24,184 shares for $129,502.91.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Sight Sciences, Inc. (SGHT) officer Alison Bauerlein reported a proposed sale of 25,260 common shares, with an aggregate market value of $223,631.83 and an approximate sale date of October 2, 2026.
The shares resulted from restricted stock vesting as compensation on September 30, 2026. The remarks say the sale includes an amount needed to cover a tax obligation from settlement of a vested equity award distribution. Joshua Schmitt signed as Fidelity Brokerage Services LLC's representative and attorney-in-fact for Bauerlein.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Vesting financial
vested equity award distribution financial
attorney-in-fact regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.